Klein Matthew B.'s Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 10, 2024
- Accession no.
- 0001415889-24-000915
- Filed
- Jan 10, 2024
- Trade date
- Jan 8-9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $222.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Matthew B.CIK 0001808968 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | Common Stock | SSaleDisposed | −2,237 | $28.64 | −$64,067.68 | 165,918 | Direct | |
| Jan 9, 2024 | Common Stock | SSaleDisposed | −5,443 | $29.01 | −$157,901.43 | 160,475 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.